table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID 19 all comersCOVID-19 mild to moderateCOVID-19 severe or critically
COVID 19 hospitalizedCOVID 19 all comersCOVID-19 mild to moderateCOVID-19 severe or critically
convalescent plasma treatment CONCOR-1 COPLA-II trial CONFIDENT Salman Baldeon ConPlas-19 CPC-SARS NCT04403477 ... Kirenga Menichetti COP-COVID-19 LACCPT ConCOVID ... CONTAIN COVID-19 NCT04442191 ASCOT PERUCONPLASMA Co-CLARITY RECOVERY ... NCT04528368 PC/COVID-19 DAWN-Plasma Bennett-Guerrero Holm K Abolghasemi NCT04397757 NCT04385199 CCAP-2 Salazar PLACO-COVID LIFESAVER PLACID Libster Duan Li Sean AlQahtani PICP19 ... Rasheed O’Donnell PlasmAr Bihariesingh-Sanchit ... Hegerova Joyner CP-COVID-19 REMAP-CAP ... Pouladzadeh ILBS-COVID-02 ... CAPSID RECOVER Sekine ... Ray

2 studies excluded by filtering options 2

5569 Dai W, 2020 2134excludednot a RCThigh risk of bias
10178 Bargay-Lleonart, 2022 210excludedrisk of bias not avaialble

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons